Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $8.81B | $8.11B | +8.67% |
Cost of Revenue | $1.19B | $1.11B | +7.06% |
Operating Income | $2.97B | $-1.26B | +335.71% |
Net Income | $2.76B | $-1.45B | +290.67% |
EPS (Basic) | $10.77 | $-5.61 | +291.98% |
EPS (Diluted) | $10.68 | $-5.61 | +290.37% |
SG&A Expense | $1.27B | $1.09B | +16.51% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $24.86B | $22.24B | +11.79% |
Current Assets | $10.57B | $9.8B | +7.81% |
Total Liabilities | $7.54B | $6.61B | +14.13% |
Current Liabilities | $4.48B | $3.97B | +12.64% |
Stockholders' Equity | $17.32B | $15.63B | +10.80% |
Cash & Equivalents | $4.94B | $5.24B | -5.72% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $3.13B | $-1.08B | +390.88% |
Investing Cash Flow | $-657.3M | $-2.95B | +77.70% |
Financing Cash Flow | $-2.18B | $-1.1B | -97.91% |
Share Buybacks | $1.89B | $759.2M | +148.81% |
D&A | $154.1M | $160.7M | -4.11% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Margin | 33.7% | -15.5% | +49.20% |
Net Margin | 31.3% | — | — |
ROE | 15.9% | — | — |
ROA | 11.1% | — | — |
Current Ratio | $2.362 | — | — |
Debt to Equity | $0.436 | — | — |
Other companies in Biotechnology